Funding for this research was provided by:
‘13th Five-Year’ National Science and Technology Major Project for New Drugs (2019ZX09734001)
National Key Research and Development Program of China (2016YFC0901500)
Beijing Natural Science Foundation (7192155)
Received: 30 August 2021
Accepted: 10 February 2022
First Online: 5 March 2022
: This study was approved by the Peking Union Medical College Hospital Ethics Committee (Ref No.: SK-814). All the participants provided informed consents before the survey was conducted.
: Not applicable.
: The authors declare that they have no competing interests.